mechanisms and implications of her2 resistance - an interview with dr. william gradishar
Published 3 years ago • 47 plays • Length 5:15Download video MP4
Download video MP3
Similar videos
-
5:21
mechanisms and implications of her2 resistance - an interview with dr. william gradishar.mp4
-
2:55
her2 biosimilars in clinical practice - an interview with dr. william gradishar
-
3:01
her2 biosimilars in clinical practice - an interview with dr. william gradishar.mp4
-
4:34
her2 cancer treatment - resistance, immunologic implications, and biosimilars.mp4
-
0:50
dr. gradishar discusses dual her2-targeting in breast cancer
-
1:26
dr. yardley on challenges with resistance mechanisms in hr /her2- breast cancer
-
2:21
dr. gradishar discusses advances in the treatment of her2-positive breast cancer
-
3:09
her2 in cancer
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
4:33
the her pathway and cancer
-
5:05
current advances and research in breast cancer - an overview.mp4
-
5:05
anti-her2 mechanisms of approved her2 inhibitors
-
1:44
dr. gradishar discusses the treatment of her2 breast cancer
-
8:10
management of her2 cancers - integrating new data into clinical practice.mp4
-
4:27
her2 cancer treatment - resistance, immunologic implications, and biosimilars
-
0:52
dr. gradishar on the role of neratinib in the treatment of her2 breast cancer
-
8:21
stereotactic radiosurgery in combination with anti-her2 therapy for her2 breast cancer brain mets
-
1:49
dr. gradishar on selecting agents for her2 breast cancer
-
1:50
two dimensions in targeting her2
-
1:58
uncovering the mechanisms behind neuropeptide y2 receptor signaling regulation